Publicaciones en las que colabora con Elena Prieto Azcárate (27)

2023

  1. Sporadic Creutzfeldt–Jakob disease is associated with reorganization of metabolic connectivity in a pathological brain network

    European Journal of Neurology, Vol. 30, Núm. 4, pp. 1035-1047

2020

  1. 18F-FDG-PET Imaging Patterns in Autoimmune Encephalitis: Impact of Image Analysis on the Results

    Diagnostics, Vol. 10, Núm. 6

  2. Multicenter Validation of Metabolic Abnormalities Related to PSP According to the MDS-PSP Criteria

    Movement Disorders, Vol. 35, Núm. 11, pp. 2009-2018

2019

  1. Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: A cross-sectional analysis from the AB255 Study

    Alzheimer's Research and Therapy, Vol. 11, Núm. 1

2017

  1. Effective dose estimation for oncological and neurological PET/CT procedures

    EJNMMI Research, Vol. 7, Núm. 1

2015

  1. Brain PET imaging optimization with time of flight and point spread function modelling

    Physica Medica, Vol. 31, Núm. 8, pp. 948-955

  2. Functional neuroimaging studies in asymmetric hearing loss

    Audiology and Neurotology

  3. Metabolic patterns in prion diseases: an FDG PET voxel-based analysis

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 42, Núm. 10, pp. 1522-1529

2014

  1. PET optimization for improved assessment and accurate quantification of 90Y-microsphere biodistribution after radioembolization

    Medical Physics, Vol. 41, Núm. 9

2013

  1. Aportación del tiempo de vuelo y de la modelización de la respuesta a una fuente puntual a las características de funcionamiento del tomógrafo PET/TAC Biograph mCT

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 32, Núm. 1, pp. 13-21

  2. Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer's disease dementia

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 40, Núm. 9, pp. 1394-1405

2012

  1. Decreased carbon-11-flumazenil binding in early Alzheimer's disease

    Brain, Vol. 135, Núm. 9, pp. 2817-2825

  2. Quantitative volumetric analysis of gliomas with sequential MRI and 11C-methionine PET assessment: Patterns of integration in therapy planning

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 39, Núm. 5, pp. 771-781

2011

  1. Dual time point 18F-FDOPA PET as a tool for characterizing brain tumors

    Revista Espanola de Medicina Nuclear, Vol. 30, Núm. 2, pp. 88-93

  2. PET de doble fase con 18F-FDOPA como instrumento para la caracterización de tumores cerebrales

    Revista española de medicina nuclear, Vol. 30, Núm. 2, pp. 88-93

  3. Voxel-based analysis of dual-time-point 18F-FDG PET images for brain tumor identification and delineation

    Journal of Nuclear Medicine, Vol. 52, Núm. 6, pp. 865-872

2010

  1. Brain glucose metabolism in vascular white matter disease with dementia: Differentiation from Alzheimer disease

    Stroke, Vol. 41, Núm. 12, pp. 2889-2893

  2. Evaluation of spatial resolution of a PET scanner through the simulation and experimental measurement of the recovery coefficient

    Computers in Biology and Medicine, Vol. 40, Núm. 1, pp. 75-80

  3. Neuroimagen: Fundamentos técnicos y prácticos

    Revista Espanola de Medicina Nuclear, Vol. 29, Núm. 4, pp. 189-210

  4. Progression of dopaminergic depletion in a model of MPTP-induced Parkinsonism in non-human primates. An 18F-DOPA and 11C-DTBZ PET study

    Neurobiology of Disease, Vol. 38, Núm. 3, pp. 456-463